Nomura Maintains Buy on Deciphera Pharmaceuticals, Raises Price Target to $84
Nomura maintains Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy and raises the price target from $57 to $84.
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
All news is property of their respective owners.
